MR spectroscopy detects lipid peaks in cerebrotendinous xanthomatosis

American Journal of Neuroradiology

Volumn 31, Issue 7, 2010, Pages 1347-1349

  Embirucu E K ^a   Otaduy, M C G ^a   Taneja, A K ^a   Leite, C C ^a   Kok, Fernando ^a   Lucato, L T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; CASE REPORT; CELL PROLIFERATION; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL EXAMINATION; GLIOSIS; HEMISPHERE; HUMAN; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; ASPARTIC ACID; CEREBELLUM; CHOLINE; HUMANS; INOSITOL; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; XANTHOMATOSIS, CEREBROTENDINOUS; YOUNG ADULT;

EID: 77955612718     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A1885     Document Type: Article

References (12)

1. Barkhof F, Verrips A, Wesseling P, et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 2000;217:869-76
2. Verrips A, Hoefsloot LH, Steenbergen GC, et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 2000;123:908-19
3. Federico A, Dotti MT. Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 2003;18:633-38
4. Gallus GN, Dotti MT, Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 2006;27:143-49 (Pubitemid 43983256)
5. Berginer VM, Gross B, Morad K, et al. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat. Pediatrics 2009;123:143-47
6. De Stefano N, Dotti MT, Mortilla M, et al. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001;124:121-31
7. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-79
8. Pilo de la Fuente B, Ruiz I, Lopez de Munain A, et al. Cerebrotendinous xanthomatosis: neuropathological findings. J Neurol 2008;255:839-42
9. Gillard JH, Waldman A, Barker P. Clinical MR neuroimaging: diffusion, perfusion, and spectroscopy. Cambridge, UK: Cambridge University Press; 2005:7-26
10. Willemsen MA, Van Der Graaf M, Van Der Knaap MS, et al. MR imaging and proton MR spectroscopic studies in Sjogren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 2004;25:649-57 (Pubitemid 38541950)
11. Oostendorp M, Engelke UF, Willemsen MA, et al. Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin Chem 2006;52:1395-405
12. Maheshwari SR, Fatterpekar GM, Castillo M, et al. Proton MR spectroscopy of the brain. Semin Ultrasound CT MR 2000;21:434-51